Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01564368 · ClinicalTrials.gov registry record · NA
DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
A NA study, sponsored by American College of Radiology Imaging Network.
- Completed
- Registry status
- NA
- Development phase
- 406
- Enrollment target
NCT01564368 is a NA study that has completed, run by American College of Radiology Imaging Network. The registered enrollment target is 406 participants.
The verdict
NCT01564368, a NA study, has completed, sponsored by American College of Radiology Imaging Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 406 participants
- Enrollment target
Study Summary
RATIONALE: Imaging procedures, such as diffusion-weighted magnetic resonance imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), may help in evaluating how well patients with breast cancer respond to treatment. PURPOSE: This research trial studies DWI and DCE-MRI in assessing treatment response in patients with breast cancer undergoing neoadjuvant chemotherapy.
Interventions
- PROCEDURE diffusion-weighted magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2012-08-27 |
| Est. Completion | 2020-01-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01564368
The ClinicalTrials.gov registry entry for NCT01564368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 406 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American College of Radiology Imaging Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which diffusion-weighted magnetic resonance imaging is the first listed.
NCT01564368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01564368 about?
NCT01564368 is a clinical study titled "DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy". RATIONALE: Imaging procedures, such as diffusion-weighted magnetic resonance imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), may help in evaluating how well patients with breast cancer respond to treatment. PURPOSE: This research trial studies DWI and DCE-MRI in as...
What is the current status of trial NCT01564368?
This trial is currently completed. It is a NA study. The enrollment target is 406 participants. The study started on 2012-08-27. Estimated completion is 2020-01-14.
What interventions are being tested in trial NCT01564368?
The interventions under investigation include: diffusion-weighted magnetic resonance imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01564368?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.